Consider the simple compliance randomized trial, in which patients randomly assigned to the experimental treatment may switch to receive the standard treatment, while patients randomly assigned to the standard treatment are all assumed to receive their assigned treatment. Six asymptotic interval estimators for the risk difference in probabilities of response among patients who would accept the experimental treatment were developed. Monte Carlo methods were employed to evaluate and compare the finite-sample performance of these estimators. An example studying the effect of vitamin A supplementation on reducing mortality in preschool children was included to illustrate their practical use.
Introduction
In randomized clinical trials, because the characteristics of the experimental treatment effect are often not completely known, some patients randomly assigned to this treatment may not comply with their assigned treatment. For example, consider the study of vitamin A supplementation to reduce mortality among preschool children in rural Indonesia (Sommer & Zeger, 1991 , Sommer, Tarwotjo, Djunaedi, et al., 1986 . Children who resided in 225 randomly selected villages out of 450 villages were assigned to receive a large oral dose of vitamin A two to three months following baseline enumeration and again six months later. Children in the remaining 225 villages would receive no vitamin A supplementation. The number of deaths in both comparison groups was ascertained in a second population census Kung-Jong Lui is Professor of Mathematics and Statistics at San Diego State University. His current research interests are in statistical methods in epidemiology and randomized clinical trials, categorical data analysis, and sample surveys. He is a fellow of the American Statistical Association, and is serving as an Associate Editor for Biometrical Journal as well as an Editorial Advisor for Journal of Probability and Statistical Science. 12 months following the baseline census. Nearly 20 percent of children assigned to the experimental group failed to receive vitamin A supplementation. The mortality rates between the groups were then compared. Because the data structure for this simple compliance study is essentially the same as that of the single consent randomized design (Zelen, 1979 , Anbar, 1983 , Brunner & Neumann, 1985 , Ellenberg, 1984 , Bernhard & Compagnone, 1989 , McHugh, 1984 , Matts & McHugh, 1987 , Lui & Lin, 2003 , all statistical methods developed here for the simple compliance trial are applicable to the latter (Sommer & Zeger, 1991 , Zelen, 1986 as well.
In this article, six asymptotic interval estimators of the risk difference between two treatments among patients who would accept the experimental treatment were developed. These included the interval estimator using Wald's statistic (Casella & Berger, 1990 , Sommer & Zeger, 1991 , the interval estimator using tanh ( )
x transformation (Edwardes, 1995 , Lui, 2002 of the maximum likelihood estimator (MLE), the interval estimator derived from a quadratic equation based on the MLE and its asymptotic properties, the interval estimator using an idea similar to that of Fieller's Theorem (Casella & Berger, 1990) , and the interval estimator using a randomization-based approach with and without the continuity correction (Mark & Robins, 1993 , Sato, 2000 . To evaluate and compare the finite sample performance of these estimators, Monte Carlo simulation was employed. Finally, an example studying the effect of vitamin A supplementation on reducing mortality in preschool children (Sommer, Tarwotjo, Djunaedi, et al., 1986) was included to illustrate their practical use.
Methods and Notations
Consider comparing an experimental treatment with a standard treatment in a simple compliance randomized trial. Patients randomly assigned to the experimental treatment are allowed to switch to receive the standard treatment, while patients randomly assigned to the standard treatment are assumed to all receive their assigned treatment. For clarity, the probabilities p ij of response for the experimental treatment are summarized in the following for i = 1, 0 and j = 1, 0 (see Table 1 ).
Similarly, the parameter p ij Table 2 ). Because a patient assigned to the experimental treatment will receive the standard treatment if he/she declines to receive the experimental treatment and because patients are randomly assigned to either treatment, the equality p i 0 = p i 0 * (for i = 1, 0) can be reasonably assumed to hold (Sommer & Zeger, 1991 
Response
Based on the intent-to-treat analysis (Zelen, 1979) , patients are compared according to the treatments to which they are originally designated despite whether patients comply with their regimen. The maximum likelihood estimator (MLE) for Δ is given by 
Based on (1) and (2), an asymptotic 100(1-α ) percent confidence interval using Wald's statistic for Δ is given by
where Z α ./2 is the upper 100 ( / ) α 2 th percentile of the standard normal distribution.
Because the sampling distribution of Δ can be skewed, interval estimator (3) may not perform well when the number of patients assigned to either treatment is not large. On the basis of some empirical results that the transformation tanh ( )( log(( ) / ( )))
been successfully applied to improve the performance of statistics relevant to the difference in proportions under other situations (Edwardes, 1995 , Lui, 2002 , this transformation is considered in this article as well. Based on the delta method again, an estimated asymptotic variance can be shown to be given by
This leads to produce an asymptotic 100(1-α ) percent confidence interval for Δ to be
Note that when both n and m are large, the
where Var( ) Δ is, as shown in Appendix, given by This suggests the following quadratic inequality:
where
To alleviate the concern that the sampling distribution of the
can be, as noted previously, skewed when n or m is small, the idea of Fieller's Theorem (Casella & Berger, 1990) 
Thus, when both n and m are large, the probability P( ( ) / ( ) )
This leads to considering the following quadratic equation:
(1 )
Following Mark and Robins (1993) , Sato (1995 Sato ( , 2000 discussed sample size calculation using a randomization-based approach in binary outcome data. Based on the same arguments as those given by (Sato, 2000 (Sato, , pp. 2691 (Sato, -2692 , an asymptotic 100(1-α ) percent confidence interval for Δ is obtained as 
Monte Carlo Simulation
To evaluate and compare the finite sample performance of interval estimators (3), (4), (6), (9), and (10) For each configuration determined by a combination of these parameters, SAS (1990) is applied to generate 10000 repeated samples of observations following the desired multinomial distributions to estimate the coverage probability and the average length. Note that if a sample led to p +1 = 0 or an estimate Δ was out of the range − < < 1 1 Δ , any interval estimator discussed here would be inapplicable.
Furthermore, if the two distinct real roots of a quadratic equation did not exist, the corresponding interval estimator could not be employed either. The estimated coverage probability and average length are calculated over those samples for which the corresponding interval estimator exists. For completeness, the probability of failing to produce a confidence interval for each interval estimator in all the above situations is also calculated. Table 3 summarizes the estimated coverage probability and average length of 95% confidence interval using interval estimators (3), (4), (6), (9), as well as the interval estimator (10) with and without the continuity correction. Note that the coverage probability of interval estimator (10) using the randomization approach without the continuity correction can be frequently less than 95% by more than 1% when the underlying difference Δ is not equal to 0.
Results
By contrast, the interval estimator (10) with the continuity correction tends to be conservative and hence lose efficiency with respect to the average length as compared with the other estimators considered here (Table 3) . Note further that interval estimators (3) and (6) are essentially equivalent and both are preferable to interval estimator (9) with respect to efficiency.
Finally, note that interval estimator (4) is consistently the most efficient with respect to the average length among all interval estimators with the coverage probability larger than or equal to the desired 95% confidence level considered here. In fact, interval estimator (4) is the only one estimator that has the estimated coverage probability larger than the 95% confidence level in all the situations discussed in Table 3 . Table 3 . The estimated coverage probability and average length (in parenthesis) of 95% confidence interval using interval estimators (3), (4), (6), (9), as well as the interval estimator (10) with and without continuity correction. Each entry is calculated on the basis of 10000 repeated samples. : means that the estimated coverage probability is less than the desired 95% confidence level by more than 1%.
: indicates that the interval estimator has the shortest average length among interval estimators subject to its estimated coverage probability less than the desired 95% confidence level by no more than 1%. Table 4 shows that except for the extreme cases where both the probability of consent p +1 and the number of patients assigned to each treatment n are small (i.e., p +1 = 0.30 and n = 30), the probability of failing to produce a 95% confidence interval by using interval estimators discussed here is generally negligible ( ≤ 0.002) in all the situations considered in Table 3 .
An Example
Consider the randomized trial of studying vitamin A supplementation to reduce the mortality among preschool children in rural Indonesia (Sommer, Tarwotjo, Djunaedi, et al., 1986) . As described previously, children were randomly assigned to either the treatment group of receiving a large oral dose of vitamin A for two to three months following baseline evaluation and again six months later, or to the control group without receiving any vitamin A supplementation. In the control group, children were precluded from receiving a placebo for ethical reasons and therefore, only the total number of survival children without the information on children who would fail to take vitamin A if they were assigned to receive this vitamin was observed. The results on mortality from month 4 (following completion of the first distribution cycle) to month 12 were compared.
As shown elsewhere (Sommer & Zeger, 1991) , the number of survival children in the control group, ( ) m 1+ = was 11,514 out of ( ) m = 11,588 children. Furthermore, the frequencies: = , n 00 34 = , were obtained for the total number 12,094 of children assigned to the treatment of receiving vitamin A. Suppose that one is interested in estimation of vitamin A effect on the non-death rate between the group receiving vitamin A and the group without receiving vitamin A supplement among children who would consent to accept vitamin A.
Given the above data, the MLE Δ is 0.0032. Applying interval estimators (3), (4), (6), (9), as well as (10) (4), (6), and (9) are essentially identical. Note that the 95% confidence interval using (10) with the continuity correction tends to have the length larger than the others. This is actually consistent with the previous findings obtained in simulations. Because all the above lower limits fall above 0, there is a significant evidence to support that taking vitamin A can increase the survival rate for preschool children at 5%-level.
Conclusion
It was found that the interval estimator (10) using the randomization-based approach with the continuity correction can lose efficiency, while this estimator without the continuity correction can be slightly liberal when the underlying difference Δ is not equal to 0. This article also finds that the interval estimator (4) using the tanh ( ) −1 Δ transformation is probably preferable to all the other estimators discussed here with respect to the coverage probability and the average length. Thus, interval estimator (4) is recommended for general use. Following Brunner and Neumann (1985) as well as Bernhard and Compagnone (1989) 
Thus, it is straightforward to extend the above discussion to account for interval estimation of this selection effect. However, the detailed derivation and discussion on the selection effect are beyond the scope of this article and can be a future possible research topic. In summary, six interval estimators for estimating the risk difference in a simple compliance randomized trial have been developed. The evaluation and comparison of the finite-sample performance of these interval estimators have been carried out in a variety of situations. The interval estimator using the tanh ( ) −1 Δ transformation of the MLE has been shown to be the best among all interval estimators for the risk difference considered here. The results and the discussion presented in this article should have use for biostatisticians and clinicians when they encounter data under a simple compliance randomized trial. Let R denote the response random variable: R = 1 if the underlying response is positive and = 0, otherwise. Furthermore, let T and C denote the random variables for the treatment assignment and the acceptance of the experimental treatment, respectively: T = 1 for the experimental treatment, and T = 0 for the standard treatment; C = 1 for accepting the experimental treatment and C = 0, otherwise. Let P R T i ( | ) = = 1 denote the probability of response for treatment i (i=1 and 0). Because patients were randomly assigned to the treatment, it may reasonably be assumed that the proportion of patients who would consent to accept the experimental between the experimental and standard treatment groups are equal (i.e., P C T P C T P C ( | ) ( | ) ( )) = = = = = = = 1 1 1 0 1
Note that
Because a patient assigned to the experimental treatment who does not consent to accept his/her assigned treatment will receive the standard treatment (i.e., T = 0), by the exclusion restriction assumption (Angrist, Imbens, & Rubin, 1996) , the equality P R T C ( | , ) is the difference in probabilities of positive response among patients who would consent to accept the experimental treatment. Say, there are n and m patients independently randomly assigned to receive the experimental and standard treatments, respectively. Let n ij (and m ij ) denote the observed frequency corresponding to the cell probability p ij (and p ij * ) in the experimental (and the standard) treatment. Then, the random vector n = ( n n n n 
